secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profusa, Inc. (PFSA)
CIK:        0001859807
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0001213900-25-100443
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profusa publishes updated investor presentation; no material specifics in filing excerpt
--------------------------------------------------------------------------------

- Updated investor presentation posted on company website on October 20, 2025.
- Presentation includes forward-looking statements and risk factors.
- No financial results, guidance, or material business updates disclosed in available excerpt.
- Company tagline: 'Pioneering real time biochemistry that drives AI-led, personalized healthcare technologies.'

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859807/000121390025100443/0001213900-25-100443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859807/000121390025100443/ea0261836-8k_profusa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-100443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer